arri test info is interesting but, with all due respect, i think a 2/3 DR test would be much more so.
the lack of 2/3 test data makes me worry whether the results are significantly less impressive and thus not something RED wishes to emphasize at this time. if that were the case, i suppose it would be understandable from a marketing standpoint.
any chance of charts soon to put such speculation to rest?



